Dinesh Khanna, MD, MSc, is Professor of Medicine and Director, University of Michigan Scleroderma Program. He holds the Frederick L. Huetwell Professorship in Rheumatology. Dr. Khanna has published over 550 peer-reviewed articles and book chapters. He is the Principal Investigator on National Institutes of Health and industry-sponsored clinical studies. He is the coordinating PI on investigator-initiated and pharmaceutical sponsored clinical trials in scleroderma. His current research focus on developing, validating, and refining outcome measures in rheumatic diseases and designing controlled trials. He received the prestigious 2015 Henry Kunkel Young Investigator Award from the American College of Rheumatology and was inducted in the 2023 American Society for Clinical Investigation.
Room Grand Ballroom 103
[International Symposium 1] For Better Management of Systemic Sclerosis
Clinical trials in evaluating new treatments for systemic sclerosis